AMGEN INC is 10.1x more valuable than Moderna, Inc. by market capitalization ($183.41 B vs $18.25 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MRNA | AMGN |
|---|---|---|
| Market cap | $18.25 B | $183.41 B |
| US-listed rank | #650 | #79 |
| Revenue (latest FY) | $1.94B | $36.75B |
| Net income (latest FY) | -$2.82B | $7.71B |
| Net margin | -145.2% | 21.0% |
| P/E (trailing FY) | - | 23.8 |
| SEC filings | 1,447 | 1,011 |
AMGEN INC is 10.1x more valuable than Moderna, Inc. by market capitalization ($183.41 B vs $18.25 B).
In their latest fiscal years, Moderna, Inc. reported $1.94B in revenue while AMGEN INC reported $36.75B.
Full pages: Moderna, Inc. and AMGEN INC, or browse the full rankings.